Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Olanow

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Annals of Neurology|January 1, 1992
An introduction to the free radical hypothesis in Parkinson's diseaseC W Olanow
Neurologic Clinics|May 1, 1992
Magnetic resonance imaging in parkinsonismC W Olanow
Neurology|July 1, 1997
Attempts to obtain neuroprotection in Parkinson's diseaseC W Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's diseaseC W Olanow
Annals of Neurology|September 28, 1998
Understanding cell death in Parkinson's diseaseP Jenner, C W Olanow
Neurology|December 1, 1996
Oxidative stress and the pathogenesis of Parkinson's diseaseP Jenner, C W Olanow
Neurology|April 1, 1992
Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?C W Olanow, D Calne
Medical Hypotheses|July 1, 1981
The pathogenesis of myasthenia gravis--a hypothesisC W Olanow, A D Roses
Annals of Neurology|June 1, 1989
Parkinsonism and amiodarone therapyE G Werner, C W Olanow
Trends in Neurosciences|October 29, 2000
Dopamine receptors: from structure to behaviorS C Sealfon, C W Olanow
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Annals of Neurology|January 1, 1992
An introduction to the free radical hypothesis in Parkinson's diseaseC W Olanow
Neurologic Clinics|May 1, 1992
Magnetic resonance imaging in parkinsonismC W Olanow
Neurology|July 1, 1997
Attempts to obtain neuroprotection in Parkinson's diseaseC W Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's diseaseC W Olanow
Annals of Neurology|September 28, 1998
Understanding cell death in Parkinson's diseaseP Jenner, C W Olanow
Neurology|December 1, 1996
Oxidative stress and the pathogenesis of Parkinson's diseaseP Jenner, C W Olanow
Neurology|April 1, 1992
Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?C W Olanow, D Calne
Medical Hypotheses|July 1, 1981
The pathogenesis of myasthenia gravis--a hypothesisC W Olanow, A D Roses
Annals of Neurology|June 1, 1989
Parkinsonism and amiodarone therapyE G Werner, C W Olanow
Trends in Neurosciences|October 29, 2000
Dopamine receptors: from structure to behaviorS C Sealfon, C W Olanow
Pageof 13